March 27, 2009 - Physio-Control Inc. has received FDA clearance to market its LIFEPAK 15 monitor/defibrillator in the U.S.
“With the LIFEPAK 15 monitor/defibrillator, Physio-Control is delivering on its commitment to provide innovative, reliable and durable equipment to emergency personnel so they can focus on the most important task at hand — saving lives,” said Brian Webster, president of Physio-Control.
For more information: www. physio-control.com
July 28, 2023 — GE HealthCare is recalling malfunctioning TruSignal sensors that may reduce the amount of energy sent to ...
July 28, 2023 
August 3, 2022 — A defibrillator administers a therapeutic shock to a patient's heart in life-threatening circumstances ...
August 03, 2022 
August 1, 2022 — A study from the University of Warwick has found that school-based defibrillators (AEDs) that are ...
August 01, 2022 
June 23, 2020 — Philips announced the U.S. Food and Drug Administration (FDA) has granted premarket approval (PMA) for ...
June 23, 2020 
April 24, 2020 — The U.S. Food and Drug Administration (FDA) has lifted its injunction prohibiting the manufacturing and ...
April 24, 2020 
January 13, 2020 — Stryker announced it is launching a voluntary field action on specific units of the LifePAK 15 ...
January 13, 2020 
June 19, 2019 — Philips announced the U.S. Food and Drug Administration (FDA) has approved the company’s premarket ...
June 19, 2019 
April 5, 2019 — Medical device startup HeartHero was the winner in the Innovation Challenge at the 2019 American College ...
April 05, 2019 
February 4, 2019 — Stryker announced Feb. 1, the company is launching a voluntary field action on specific units of the ...
February 04, 2019 
Following the Vest Prevention of Early Sudden Death Trial (VEST) presentation at the 2018 American College of Cardiology ...
July 10, 2018